---
schema_version: "secwatch.filing_event.v1"
accession: "0001770787-25-000035"
form_type: "8-K"
ticker: "TXG"
cik: "0001770787"
company_name: "10x Genomics, Inc."
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T09:25:48.613845+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# 10x Genomics settles patent litigation with Bruker; to receive $68M upfront plus royalties

## Summary
- Settled all patent litigation with Bruker (formerly NanoString) regarding spatial biology platforms; all claims dismissed with prejudice.
- 10x expects $68M in upfront nonrefundable payments, paid in equal quarterly installments with interest from Q3 2025 to Q2 2026.
- Ongoing royalty payments on licensed products and services for the life of the licensed patents.
- Litigation began in 2021–2022 targeting NanoString's GeoMx and CosMx spatial platforms; Bruker assumed liabilities in May 2024.

## SEC filing metadata
- accession: 0001770787-25-000035
- form_type: 8-K
- ticker: TXG
- cik: 0001770787
- company_name: 10x Genomics, Inc.
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770787/000177078725000035/0001770787-25-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770787/000177078725000035/txg-20250512.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001770787-25-000035
- JSON: https://secwatch.observer/filing/0001770787-25-000035.json
- Plain text: https://secwatch.observer/filing/0001770787-25-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.